Merck & Co.

Latest Stories

A Merck scientist conducts research on Feb. 28, 2013, in West Point, Pa. Merck is suing the federal government Tuesday, June 6, 2023, over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion. The drugmaker is seeking to halt the program, which was laid out in the Inflation Reduction Act and is expected to save taxpayers billions of dollars in the coming years. (AP Photo/Matt Rourke) **FILE**

Merck sues to stop Biden’s drug-negotiation program, calls it ‘extortion’

By Tom Howell Jr. - The Washington Times

Indiana Congressman Stephen Buyer talks during a Hoosier Job Fair, July 19, 2010, at Jefferson High School in Lafayette, Ind. The former U.S. congressman from Indiana, technology company executives and an investment banker are among nine people charged in four separate and unrelated insider trading schemes. The charges were announced Monday, July 25, 2022 in Manhattan. (Michael Heinz/Journal & Courier via AP) **FILE**

Ex-U.S. congressman among 9 charged in insider trading cases

By Larry Neumeister - Associated Press

In this Dec. 18, 2014, file photo, a person walks through a Merck company building in Kenilworth, N.J. (AP Photo/Mel Evans, File) ** FILE **

New era begins at Merck as pandemic cuts Q1 sales, profit

By LINDA A. JOHNSON - Associated Press

President Joe Biden speaks about efforts to combat COVID-19, in the State Dining Room of the White House, Tuesday, March 2, 2021, in Washington. (AP Photo/Evan Vucci)

Biden stands by May timeline for vaccines for all US adults

By ZEKE MILLER and LINDA A. JOHNSON and JONATHAN LEMIRE - Associated Press

FILE - This September 2020, file photo provided by Johnson &amp; Johnson shows a pharmacist preparing to give an experimental COVID-19 vaccine. The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday, Feb. 27, 2021 cleared a Johnson &amp; Johnson shot that works with just one dose instead of two. (Johnson &amp; Johnson via AP, File)

Biden vows enough vaccine for all US adults by end of May

By ZEKE MILLER and LINDA A. JOHNSON and JONATHAN LEMIRE - Associated Press

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck posted a big fourth-quarter loss, mainly due to much higher spending on research, production and overhead, and announced longtime chief executive, Kenneth Frazier, will retire on July 1, 2021. (AP Photo/Seth Wenig, File)

Longtime Merck CEO, minority advocate Ken Frazier to retire

By LINDA A. JOHNSON - Associated Press

This May 1, 2018, photo shows Merck corporate headquarters in Kenilworth, N.J. The drugmaker will stop developing two potential COVID-19 vaccines after seeing poor results in early-stage studies. The company said Monday, Jan. 25, 2021, that it will focus instead on studying two possible treatments for the virus that also have yet to be approved by regulators. (AP Photo/Seth Wenig) **FILE**

Merck ends development of two potential COVID-19 vaccines

By TOM MURPHY - Associated Press

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. The pandemic increased sales of Merck medicines during the first quarter of 2020, as households around the world stocked up, but the drugmaker expects a significant hit this quarter as the full force of the outbreak lands. (AP Photo/Seth Wenig, File)

Merck ups outlook, turns profit during global vaccine hunt

By LINDA A. JOHNSON - Associated Press

Merck plans $100M expansion at Kansas manufacturing facility

Associated Press

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. The pandemic increased sales of Merck medicines during the first quarter of 2020, as households around the world stocked up, but the drugmaker expects a significant hit this quarter as the full force of the outbreak lands. (AP Photo/Seth Wenig, File)

Merck expects brunt of pandemic will strike this quarter

By LINDA A. JOHNSON - Associated Press

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck is posting a 29% jump in fourth-quarter profit and it's spinning off its women's health division and other operations that churn out $6.5 billion in annual revenues. The drugmaker on Wednesday, Feb. 5, 2020 reported net income of $2.36 billion, up from $1.83 billion, a year earlier. (AP Photo/Seth Wenig, File)

Merck to spin off assets with $6.5B in sales; 4Q profit up

By LINDA A. JOHNSON - Associated Press

FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck &amp; Co. reports earnings Friday, Feb. 1, 2019. (AP Photo/Seth Wenig, File)

Merck 4Q net powered by cancer treatment sales, lower taxes

By LINDA A. JOHNSON - Associated Press

High court seems likely to side with Merck in Fosamax case

By JESSICA GRESKO - Associated Press

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck &amp; Co. reports earnings Thursday, Oct. 25. (AP Photo/Seth Wenig, File)

Merck posts global sales of $11B in third quarter

By LINDA A. JOHNSON - Associated Press

FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck &amp; Co. on Friday, July 27 reported second-quarter profit of $1.71 billion. The Kenilworth, New Jersey-based company said it had profit of 63 cents per share. Earnings, adjusted for costs related to mergers and acquisitions and restructuring costs, were $1.06 per share. (AP Photo/Seth Wenig, File)

Merck beats views on sales jumps for cancer drugs, vaccines

By LINDA A. JOHNSON - Associated Press

Tax overhaul charge hands Merck 4Q loss despite higher sales

By LINDA A. JOHNSON - Associated Press

FILE - This Thursday, Dec. 18, 2014, file photograph, shows a sign at the Merck company facilities in Kenilworth, N.J. Merck &amp; Company, Inc. reports earnings, Friday, Oct. 27, 2017. (AP Photo/Mel Evans, File)

Merck swings to 3Q loss on big charge but raises forecast

By LINDA A. JOHNSON - Associated Press

Correction: FDA-Shingles Vaccine story

By The Associated Press - Associated Press

Belgian scientists claim Delaware wrongly seized, sold stock

By RANDALL CHASE - Associated Press

FILE - In this Thursday, Dec.18, 2014, file photograph, scientist Christopher Kistler checks on experiments in AMBR250 bio-reactors in a laboratory at the Merck company facilities in Kenilworth, N.J. Merck &amp; Company, Inc. reports earnings, Friday, July 28, 2017. (AP Photo/Mel Evans, File)

A strong 2Q for Merck, outlook mixed

By LINDA A. JOHNSON - Associated Press